Alnylam Pharmaceuticals, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
USD
328.16
-3.08 (-0.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-0.93%
1.97%
1W
-2.93%
-0.1%
1M
-19.25%
-0.18%
YTD
-17.48%
1.27%
1Y
17.94%
13.95%
3Y
46.41%
68.62%
5Y
98.75%
78.35%
10Y
98.75%
268.73%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.5%
0%
-25.5%
6 Months
-23.35%
0%
-23.35%
1 Year
17.94%
0%
17.94%
2 Years
90.59%
0%
90.59%
3 Years
46.41%
0%
46.41%
4 Years
125.66%
0%
125.66%
5 Years
98.75%
0%
98.75%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary